Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Given Average Recommendation of “Reduce” by Analysts

Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY) have been assigned an average rating of “Reduce” from the five brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company.

A number of research analysts have issued reports on the company. UBS Group downgraded Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research note on Tuesday, August 11th. Zacks Research lowered shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 11th.

Carl Zeiss Meditec Price Performance

OTCMKTS CZMWY opened at $35.94 on Tuesday. Carl Zeiss Meditec has a 12 month low of $26.65 and a 12 month high of $55.94. The business has a fifty day simple moving average of $32.49 and a 200 day simple moving average of $31.13.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.